Elevidys (Delandistrogene Moxeparvovec) for Duchenne Muscular Dystrophy

Type: gene_therapy

Status: FDA Approved (Accelerated Approval)

Developer: Sarepta Therapeutics

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026